Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on peripheral stem cell transplantation for hematologic cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED